-
-
-
-
-
-
-
Lantern Pharma launches ZetaOmics cancer bioinformatics tool
-
-
-
-
-
-
-
New to The Street Broadcasts Episode 753 Today at 6:30 PM EST Across Bloomberg Television U.S., MENA, and Latin America Featuring Leaders in VR Defense Training, AI Streaming, Healthcare Innovation, a
-
-
-
-
-
-
-
Lantern Pharma launches withZeta.ai commercial platform for cancer research
-
-
-
-
-
-
-
New to The Street to Broadcast Show Number 698 on Bloomberg - Saturday, November 8, 2025, at 6:30 PM EST
-
-
-
-
-
-
-
Lantern Pharma (LTRN) Tops Q2 EPS by 13c
-
-
-
-
-
-
-
Lantern Pharma (LTRN) Reports Q1 Loss of $0.42
-
-
-
-
-
-
-
Lantern Pharma's (LTRN) Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA
-
456,990 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

